A key focus for Illumina continues to be the transition to its NovaSeq X platform, which is progressing according to plan. The company reported over 50 NovaSeq X instrument placements in Q2 2025, with ...
Company News Published 10/30/2025, 02:29 PM 0 Algoma Steel Q3 2025 slides: Accelerating EAF transition amid widening losses ASTL -1.28% ...
While ARR growth remains strong, Varonis acknowledged that its transition to a SaaS-based business model is creating near-term headwinds. The company reported that increased SaaS sales in the bookings ...
Microba Life Sciences Ltd (ASX:MAP) reported its Q1 FY26 results on October 28, 2025, highlighting significant growth in its core diagnostic products despite an overall flat revenue performance. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback